| RS1570426424 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Isolated macular dystrophy, Isolated macular dystrophy |
| RS1570426448 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS1570427705 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS1570428456 |
MUTYH
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1570433022 |
MUTYH
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS1570433137 |
ABCA4
|
Health Risk |
Likely pathogenic |
Stargardt disease, Stargardt disease |
| RS1570433288 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1570433472 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease IIIa, Glycogen storage disease IIIa |
| RS1570433686 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1570438459 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1570442236 |
AGL
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1570443086 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS1570443585 |
MUTYH
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1570443687 |
MUTYH
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS1570444542 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1570445130 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1570452214 |
P3H1
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type 8, Osteogenesis imperfecta type 8 |
| RS1570452407 |
P3H1
|
Health Risk |
Pathogenic/Likely pathogenic |
Osteogenesis imperfecta type III, Osteogenesis imperfecta type 8 |
| RS1570453963 |
P3H1
|
Health Risk |
Pathogenic/Likely pathogenic |
Osteogenesis imperfecta type III, Osteogenesis imperfecta |
| RS1570454914 |
P3H1
|
Health Risk |
Pathogenic/Likely pathogenic |
Osteogenesis imperfecta type 8, Osteogenesis imperfecta type 8 |
| RS1570463842 |
PGM1
|
Health Risk |
Pathogenic |
PGM1-congenital disorder of glycosylation, PGM1-congenital disorder of glycosylation |
| RS1570464856 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS1570465624 |
MUTYH
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 2, Familial adenomatous polyposis 2 |
| RS1570467133 |
MUTYH
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1570467252 |
PPT1
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis 1, Neuronal ceroid lipofuscinosis 1 |
| RS1570470199 |
MPL
|
Health Risk |
Pathogenic |
Essential thrombocythemia, Congenital amegakaryocytic thrombocytopenia |
| RS1570470281 |
PPT1
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 1, Neuronal ceroid lipofuscinosis 1 |
| RS1570470323 |
MPL
|
Health Risk |
Likely pathogenic |
Congenital amegakaryocytic thrombocytopenia, Essential thrombocythemia |
| RS1570472103 |
MPL
|
Health Risk |
Pathogenic |
Congenital amegakaryocytic thrombocytopenia 1, Congenital amegakaryocytic thrombocytopenia 1 |
| RS1570472113 |
P3H1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 8, Osteogenesis imperfecta type 8 |
| RS1570472144 |
MPL
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital amegakaryocytic thrombocytopenia, Essential thrombocythemia |
| RS1570473609 |
MTHFR
|
Health Risk |
Pathogenic |
Homocystinuria due to methylene tetrahydrofolate reductase deficiency, Homocystinuria due to methylene tetrahydrofolate reductase deficiency |
| RS1570474015 |
MPL
|
Health Risk |
Likely pathogenic |
Congenital amegakaryocytic thrombocytopenia 1, Congenital amegakaryocytic thrombocytopenia |
| RS1570475998 |
MTHFR
|
Health Risk |
Pathogenic |
Neural tube defects, folate-sensitive |
| RS1570476221 |
PPT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuronal ceroid lipofuscinosis 1, Neuronal ceroid lipofuscinosis 1 |
| RS1570479611 |
P3H1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta, Osteogenesis imperfecta |
| RS1570486718 |
ELOVL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ichthyotic keratoderma, spasticity |
| RS1570487381 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Thyroid cancer |
| RS1570497770 |
ARHGAP29
|
Health Risk |
Pathogenic |
Nonsyndromic cleft lip with or without cleft palate, Nonsyndromic cleft lip with or without cleft palate |
| RS1570497904 |
NFIA
|
Health Risk |
Likely pathogenic |
— |
| RS1570504754 |
NPHP4
|
Health Risk |
Likely pathogenic |
Nephronophthisis 4, Nephronophthisis 4 |
| RS1570508240 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease IIIa, Glycogen storage disease IIIa |
| RS1570514784 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1570520175 |
SVBP
|
Health Risk |
Pathogenic/Likely pathogenic |
Lower limb spasticity, Microcephaly |
| RS1570520229 |
SVBP
|
Health Risk |
Pathogenic |
Microcephaly, Intellectual disability |
| RS1570539863 |
ARID1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1570562309 |
GNAT2
|
Health Risk |
Pathogenic |
Achromatopsia 4, Achromatopsia 4 |
| RS1570565168 |
GNAT2
|
Health Risk |
Likely pathogenic |
— |
| RS1570566590 |
RPL11
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia 7, Diamond-Blackfan anemia |
| RS1570566592 |
RPL11
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia |
| RS1570566714 |
RPL11
|
Health Risk |
Likely pathogenic |
Anemia, Reticulocytopenia |
| RS1570569383 |
RPL11
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia |
| RS1570588220 |
CSF3R
|
Health Risk |
Pathogenic |
Autosomal recessive severe congenital neutropenia due to CSF3R deficiency, Autosomal recessive severe congenital neutropenia due to CSF3R deficiency |
| RS1570590528 |
SLC2A1
|
Health Risk |
Likely pathogenic |
Childhood onset GLUT1 deficiency syndrome 2, Childhood onset GLUT1 deficiency syndrome 2 |
| RS1570590834 |
SLC2A1
|
Health Risk |
Likely pathogenic |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS1570590859 |
SLC2A1
|
Health Risk |
Pathogenic |
Encephalopathy due to GLUT1 deficiency, Encephalopathy due to GLUT1 deficiency |
| RS1570590876 |
SLC2A1
|
Health Risk |
Conflicting classifications of pathogenicity |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS1570590905 |
SLC2A1
|
Health Risk |
Likely pathogenic |
Encephalopathy due to GLUT1 deficiency, Encephalopathy due to GLUT1 deficiency |
| RS1570591031 |
SLC2A1
|
Health Risk |
Pathogenic |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS1570591037 |
SLC2A1
|
Health Risk |
Pathogenic |
— |
| RS1570592604 |
SLC2A1
|
Health Risk |
Pathogenic |
Global developmental delay, Strabismus |
| RS1570592618 |
SLC2A1
|
Health Risk |
Conflicting classifications of pathogenicity |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS1570592655 |
SLC2A1
|
Health Risk |
Pathogenic |
— |
| RS1570592813 |
SLC2A1
|
Health Risk |
Likely pathogenic |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS1570592844 |
SLC2A1
|
Health Risk |
Pathogenic |
Encephalopathy due to GLUT1 deficiency, Encephalopathy due to GLUT1 deficiency |
| RS1570592933 |
SLC2A1
|
Health Risk |
Pathogenic |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS1570593449 |
SLC2A1
|
Health Risk |
Pathogenic |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS1570593475 |
SLC2A1
|
Health Risk |
Pathogenic |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS1570593487 |
SLC2A1
|
Health Risk |
Pathogenic |
— |
| RS1570593595 |
SLC2A1
|
Health Risk |
Pathogenic |
— |
| RS1570593621 |
SLC2A1
|
Health Risk |
Pathogenic |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS1570593665 |
SLC2A1
|
Health Risk |
Pathogenic |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS1570593820 |
SLC2A1
|
Health Risk |
Pathogenic |
Encephalopathy due to GLUT1 deficiency, Encephalopathy due to GLUT1 deficiency |
| RS1570593865 |
SLC2A1
|
Health Risk |
Conflicting classifications of pathogenicity |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS1570593881 |
SLC2A1
|
Health Risk |
Pathogenic |
— |
| RS1570593893 |
SLC2A1
|
Health Risk |
Pathogenic |
— |
| RS1570600997 |
SLC2A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, Intellectual disability |
| RS1570601007 |
SLC2A1
|
Health Risk |
Likely pathogenic |
Encephalopathy due to GLUT1 deficiency, Encephalopathy due to GLUT1 deficiency |
| RS1570601051 |
SLC2A1
|
Health Risk |
Pathogenic |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS1570601060 |
SLC2A1
|
Health Risk |
Likely pathogenic |
Encephalopathy due to GLUT1 deficiency, Encephalopathy due to GLUT1 deficiency |
| RS1570601100 |
SLC2A1
|
Health Risk |
Conflicting classifications of pathogenicity |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS1570607996 |
ARID1A
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 14 |
| RS1570609440 |
ARID1A
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 14 |
| RS1570615526 |
SLC35A3
|
Health Risk |
Likely pathogenic |
Autism spectrum disorder - epilepsy - arthrogryposis syndrome, Autism spectrum disorder - epilepsy - arthrogryposis syndrome |
| RS1570619302 |
SLC16A1
|
Health Risk |
Pathogenic |
Ketoacidosis due to monocarboxylate transporter-1 deficiency, Exercise-induced hyperinsulinism |
| RS1570621473 |
TOE1
|
Health Risk |
Pathogenic/Likely pathogenic |
Pontocerebellar hypoplasia type 7, Pontocerebellar hypoplasia type 7 |
| RS1570621555 |
TOE1
|
Health Risk |
Likely pathogenic |
Pontocerebellar hypoplasia type 7, Pontocerebellar hypoplasia type 7 |
| RS1570621899 |
ARID1A
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 14 |
| RS1570622663 |
ARID1A
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 14 |
| RS1570623368 |
ARID1A
|
Health Risk |
Likely pathogenic |
— |
| RS1570623881 |
SLC16A1
|
Health Risk |
Likely pathogenic |
Exercise-induced hyperinsulinism, Exercise-induced hyperinsulinism |
| RS1570625903 |
SLC35A3
|
Health Risk |
Pathogenic |
Autism spectrum disorder - epilepsy - arthrogryposis syndrome, Autism spectrum disorder - epilepsy - arthrogryposis syndrome |
| RS1570626350 |
TOE1
|
Health Risk |
Likely pathogenic |
Pontocerebellar hypoplasia type 7, Pontocerebellar hypoplasia type 7 |
| RS1570630126 |
COL11A1
|
Health Risk |
Likely pathogenic |
— |
| RS1570630665 |
GALE
|
Health Risk |
Pathogenic/Likely pathogenic |
UDPglucose-4-epimerase deficiency, UDPglucose-4-epimerase deficiency |
| RS1570632355 |
DPYD
|
Health Risk |
Likely pathogenic |
Dihydropyrimidine dehydrogenase deficiency, Dihydropyrimidine dehydrogenase deficiency |
| RS1570640673 |
GNB1
|
Health Risk |
Pathogenic |
Dystonic disorder, Atypical behavior |
| RS1570643880 |
SLC35D1
|
Health Risk |
Pathogenic |
Schneckenbecken dysplasia, Schneckenbecken dysplasia |
| RS1570654979 |
NOTCH2
|
Health Risk |
Likely pathogenic |
Hajdu-Cheney syndrome, Hajdu-Cheney syndrome |
| RS1570655570 |
NOTCH2
|
Health Risk |
Likely pathogenic |
Alagille syndrome due to a NOTCH2 point mutation, Alagille syndrome due to a NOTCH2 point mutation |